API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.baxter.com/baxter-newsroom/baxter-expands-pharmaceuticals-portfolio-new-injectable-products-us#:~:text=Baxter%20offers%20the%20first%20and,Vasopressin%20in%20a%20flexible%20container.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-norepinephrine-bitartrate-in-09-sodium-chloride-34421.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-19-2023-50304.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-gets-usfda-nod-to-market-generic-blood-pressure-lowering-drug/articleshow/93022717.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216341
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-30-2022-1648618596.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-02-2022-1646291076.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf
https://www.prnewswire.com/news-releases/breckenridge-pharmaceutical-inc-announces-launch-of-norepinephrine-bitartrate-injection-usp-generic-for-levophed-301359736.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214323
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211382
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-1-2020-1577869200.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210839
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203662
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211359
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211242
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-25-2018-1532506531.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-11-2018-1531283050.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf
https://www.pharmacompass.com/pdf/news/hospira-issues-voluntary-worldwide-recall-for-lots-of-hydromorphone-hcl-injection-usp-cii-2-mgml-1mgml-vial-levophed-1504322332.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-16-2017-1502850779.pdf